NAD+ providers, graded on 4 checks

Compare NAD+ providers by form first, then by grade

Every provider here carries the same 4 checks: a licensed US pharmacy, a prescriber who reviews you first, a price you can see before signup, and no research-only products. A provider's grade is its count of passes, so 4 of 4 is an A and 3 of 4 is a B.

NAD+ reaches you on this board in 9 forms: nasal spray, cream, injection, sublingual, tablet, oral liquid, lozenge (troche), capsule and iV infusion. 42 of the 48 providers sell an injectable form and 20 sell a nasal spray, so many offer more than one. Settle the form with your prescriber before you compare prices. A row's "From" figure is that provider's lowest-priced form, and it may not be the form you want.

Next, read the chips, not only the letter. With 4 A grades and 30 B grades here, the letter alone won't narrow 48 names very far. The chip that shows a Flag tells you what to ask that provider.

No provider here is a Partner, so the order inside each grade is plain alphabetical. The order never tracks price. To compare cost, use the table above, which puts each provider's standing monthly figure next to its grade.

Each provider's name opens its full check: the reason for every Pass or Flag and the page it came from. How we check sets out what each check accepts as proof.

What each check means when the product is NAD+

Licensed US pharmacy. There is no FDA-approved NAD+ product, so every injection, spray and cream on this board is compounded to order. The pharmacy that makes it answers for what is in the vial. 27 of the 48 NAD+ providers get a Flag here because their own pages don't name a dispensing pharmacy that shows an active license. That one check accounts for 27 of the 44 grades below an A.

Prescriber reviews you first. A compounded NAD+ product is a prescription, so a clinician has to approve it before a pharmacy fills it. All 48 providers state that step on their own pages. The check doesn't grade how long the visit runs or whether it happens by video. It asks only that a clinician reviews your intake before a prescription is written or anything ships.

Price shown before signup. A first-month offer doesn't count on this check. Only the month-to-month rate a new buyer pays, visible before you give contact details, earns a Pass. 26 providers on this board miss it, which is a different thing from charging more.

No research-only products. NAD+ itself does not trigger this catalog check. Its Category 1 status is conditional interim evaluation, not product approval. The check reads the rest of the catalog for products labeled "research use only" and experimental products needing regulatory clarification. 5 providers sell one, and the check page names the product.

NAD+ cost math: per month, per year and per charge

Standing monthly NAD+ prices on this board run from $94.99 to $279, with a median of $159 across the 25 providers that publish one. Over 12 months that comes to $1,139.88 at the low end and $3,348 at the high end. Any separate visit or lab fee a provider charges is additional to those totals.

The form changes the figure: the lowest injectable figure is $129 a month, the lowest nasal spray is $94.99, the oral forms start at $100 and creams start at $95. Price the form your prescriber plans to write, not the one that makes the row look lowest.

The lowest standing prices on this board sit on rows graded below an A. The lowest A-graded figure is ARSYNL Rx at $149 a month. That is $54.01 a month above the floor, or $648.12 over a year, for a provider that passes all 4 checks.

Enhance MD bills $99 every 28 days. That annualizes to $1,290.54 over 365 days. With a day-zero payment, fourteen charges can fall within the first 365 days. 4 other providers bill NAD+ the same way. Those rows show the calendar-month figure, by our math.

23 providers print "Not published up front" in place of a price. That means no standing monthly NAD+ rate is public, not that the product is free or cheap.

Where NAD+ stands with FDA

NAD+ is not an FDA-approved drug. FDA keeps it in Category 1 of its 503A bulk-substance list, an interim evaluation status with conditional enforcement discretion. The remaining statutory and policy conditions still apply. That is why every product on this board is compounded and no brand-name NAD+ appears on it.

Compounded drugs don't go through an FDA review of safety, effectiveness or quality before they ship. Each lot is only as good as the pharmacy's own testing, which is why the pharmacy check matters so much on this board.

On evidence, the NAD+ page describes a 2026 review that found no eligible IV or intramuscular wellness outcome trial within its 2010–2025 search. That limited finding is not proof that every later study or route lacks research. A price comparison can't change that. Read whether NAD+ injections work and what the safety record shows before you pay for a course. NAD+ nasal spray covers the spray on its own terms.